NDC properties for NDC 9 0591-2921
NDC item 00591292102
| NDC 9 | 0591-2921 |
|---|---|
| NDC 10 | 0591-2921-02 |
| NDC Item | 00591292102 |
| packaging | 2 BOTTLE, PUMP in 1 CARTON (0591-2921-02) / 75 g in 1 BOTTLE, PUMP (0591-2921-18) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-14 |
| Marketing status | ACTIVE |
NDC item 00591292118
| NDC 9 | 0591-2921 |
|---|---|
| NDC 10 | 0591-2921-18 |
| NDC Item | 00591292118 |
| packaging | 75 g in 1 BOTTLE, PUMP |
| ANDA | ANDA076737 |
| DCSA | CIII |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-14 |
| Marketing status | ACTIVE |
NDC item 00832112140
| NDC 9 | 0832-1121 |
|---|---|
| NDC 10 | 0832-1121-40 |
| NDC Item | 00832112140 |
| packaging | 60 in 1 BOTTLE, PUMP |
| COLORTEXT | white(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
NDC item 00832112142
| NDC 9 | 0832-1121 |
|---|---|
| NDC 10 | 0832-1121-42 |
| NDC Item | 00832112142 |
| packaging | 2 BOTTLE, PUMP in 1 CARTON (0832-1121-42) / 60 GEL, METERED in 1 BOTTLE, PUMP (0832-1121-40) |
| COLORTEXT | white(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
NDC item 21922001947
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-47 |
| NDC Item | 21922001947 |
| packaging | 2 CONTAINER in 1 CARTON (21922-019-47) / 75 g in 1 CONTAINER |
| ANDA | ANDA212984 |
| DCSA | CIII |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
NDC item 66993095344
| NDC 9 | 66993-953 |
|---|---|
| NDC 10 | 66993-953-44 |
| NDC Item | 66993095344 |
| packaging | 2 BOTTLE, PUMP in 1 CARTON (66993-953-44) / 88 g in 1 BOTTLE, PUMP (66993-953-88) |
| DCSA | CIII |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2025-05-19 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021015 |
NDC item 66993095388
| NDC 9 | 66993-953 |
|---|---|
| NDC 10 | 66993-953-88 |
| NDC Item | 66993095388 |
| packaging | 88 g in 1 BOTTLE, PUMP |
| DCSA | CIII |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2025-05-19 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA021015 |